UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Price cut, expanded indication to prop up cholesterol-reducing PCSK9 inhibitors
by Kim Yun-mi
2019-02-13 16:11
Mediforum gets ₩19 billion investment
by Lee Han-soo
2019-02-13 15:19
Genexine, SCM Life Science acquire Argos Therapeutics
by Lee Han-soo
2019-02-13 15:17
CJ Healthcare to export gastroesophageal reflux treatment to Latin America
by Lee Han-soo
2019-02-13 10:50
GC posts ₩1.3 trillion in 2018 sales
by Lee Han-soo
2019-02-13 10:50
라인
Bridge Biotherapeutics unveils clinical trials results for ulcerative colitis treatment
by Lee Han-soo
2019-02-12 17:38
AbbVie’s new hepatitis C treatment outpaces Gilead’s rival drugs
by Kim Yun-mi
2019-02-12 15:56
Pfizer Korea voluntarily recalls antibiotic Zyvox
by Lee Hye-seon
2019-02-12 15:56
SK Chemical to co-promote Janssen’s dementia treatment
by Lee Han-soo
2019-02-12 15:55
Demands for MMR vaccines spike amid resurgence of measles
by Park Gi-taek
2019-02-12 11:19
라인
IVI to cooperate with CEPI to develop vaccines
by Lee Han-soo
2019-02-11 16:41
Gilead’s hepatitis B drug posts disappointing sales in 2018
by Kim Yun-mi
2019-02-11 15:29
Sales of antidiabetic SGLT-2 inhibitors expand 40% in 2018
by Kim Yun-mi
2019-02-11 14:35
Novo Nordisk has high expectations for GLP-1 receptor agonists
by Kim Yun-mi
2019-02-08 17:11
Bioneer’s HIV diagnostic kit registered on Global Fund’s purchase list
by Park Gi-taek
2019-02-08 16:46
라인
Pangen wins Malaysia’s nod for epoetin alfa biosimilar
by Lee Han-soo
2019-02-08 16:13
Sanofi seeks to add cholesterol-lowering drug’s new indication in Korea
by Kim Yun-mi
2019-02-08 16:12
Multinationals prepare next-generation pneumococcal vaccines
by Kim Yun-mi
2019-02-08 12:02
Kainos Medicine starts developing treatment for multiple system atrophy
by Lee Han-soo
2019-02-08 11:47
‘Novartis’ Cosentyx, a cost-effective alternative to Humira’
by Lee Han-soo
2019-02-07 17:14
-
이전
51
52
53
54
55
56
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top